TrialThe Lancet. Oncology2022

Effect of dexamethasone on dyspnoea in patients with cancer (ABCD): a parallel-group, double-blind, randomised, controlled trial.

David Hui et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.